Stages I-II Gastric Cancer


Proton Beam Therapy May Improve Outcomes for Esophageal Cancer (January 23, 2017)

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for... Continue Reading

Reolysin® Receives FDA Designation for Gastric Cancer (May 14, 2015)

The U.S. Food and Drug Administration (FDA) has granted an Orphan Drug Designation (ODD) to Reolysin®, an injectable cancer-killing virus, for the treatment of gastric cancer. Oncolytics Biotech® Inc.... Continue Reading

U.S. FDA Issues Warning about Certain Type of Endoscope (February 20, 2015)

The U.S. Food and Drug Administration (FDA) has issued a Safety Communication about a certain type of endoscope­—specifically the device used in endoscopic retrograde cholangiopancreatography (ERCP).... Continue Reading

New Online Support Group for People Affected by Gastrointestinal Conditions: IBS, Crohn’s, UC, GERD, Cancer and More (August 14, 2014)

Are you suffering from a gastrointestinal (GI) tract condition? You are not alone! TheGIConnection is now available for patients, caregivers, and health consumers as an up to date online information resource... Continue Reading

Adjuvant Radiochemotherapy Demonstrates Benefit in Gastric Cancer (September 25, 2012)

Adjuvant radiochemotherapy provides strong and persistent benefit in patients who have undergone curative gastric resection, according to the long-term results of a study published in the Journal of Clinical... Continue Reading

XELOX May Improve Survival in Gastric Cancer (June 24, 2011)

The chemotherapy regimen referred to as XELOX may improve overall survival compared with observation alone in stages II and III gastric (stomach) cancer; however, data are still immature and longer follow-up... Continue Reading

Genetic Variant Associated with Poor Outcome for Gastric Cancer (May 24, 2010)

Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the... Continue Reading

Adjuvant Chemotherapy Clinical Trial Data from Last 30 Years Evaluated to Determine Benefit in Gastric Cancer (May 14, 2010)

A moderate but statistically significant survival benefit was reported with the addition of chemotherapy to surgery in patients with resectable gastric cancer (gastric cancer that can be surgically removed).... Continue Reading

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer (August 4, 2008)

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer Among patients diagnosed with gastric (stomach) cancer, a combination of antibiotics against the bacterium Helicobacter... Continue Reading

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers (July 23, 2008)

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers Researchers recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic... Continue Reading

Combination of Chemotherapy and Immunotherapy Shows Promise for Gastric Cancer (March 24, 2008)

Combination of Chemotherapy and Immunotherapy Shows Promise for Gastric Cancer A combination of chemotherapy and immunotherapy (chemoimmunotherapy) may improve overall survival among gastric cancer patients.... Continue Reading

Identification of Cellular Enzymes May Predict Prognosis of Gastric Cancer (February 27, 2008)

Identification of Cellular Enzymes May Predict Prognosis of Gastric Cancer An important enzyme known as histone deacetylase may contain useful information about the prognosis of gastric cancer. These findings... Continue Reading

Stage II Gastric Cancer (February 20, 2008)

OVERVIEW Patients with Stage II gastric cancer have cancer that involves deeper layers of the stomach and/or nearby lymph nodes. A variety of factors ultimately influence a patient’s decision to receive... Continue Reading

Stage I Gastric Cancer (February 20, 2008)

OVERVIEW Patients with Stage I gastric cancer have cancer that invades beneath the surface layer of cells lining the stomach. The cancer is referred to as Stage IA if the cancer does not involve the bladder... Continue Reading

S-1 Chemotherapy Following Surgery Improves Survival in Gastric Cancer (November 1, 2007)

S-1 Chemotherapy Following Surgery Improves Survival in Gastric Cancer According to an article recently published in the New England Journal of Medicine, treatment with the chemotherapy agent S-1 following... Continue Reading

PET Imaging May Help Guide Treatment of Esophageal and Gastric Cancers (September 21, 2007)

PET Imaging May Help Guide Treatment of Esophageal and Gastric Cancers According to the results of a study published in Lancet Oncology, use of positron emission tomography (PET) imaging to evaluate response... Continue Reading

More Chemotherapy Not Beneficial in Gastric Cancer (April 23, 2007)

More Chemotherapy Not Beneficial in Gastric Cancer According to an article recently published in the Journal of the National Cancer Institute, intensive weekly chemotherapy with the regimen referred to... Continue Reading

Oral Agent May Reduce Risk of Recurrences in Early Gastric Cancer (January 23, 2007)

Oral Agent May Reduce Risk of Recurrences in Early Gastric Cancer According to a press release from Sanofi-Aventis and results presented at the 2007 annual meeting of the American Society of Clinical Oncology... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS